Symptomatic Treatment of MS - European Multiple Sclerosis Platform

260. The FOOD Trial Collaboration (2005) Effect of timing and method of enteral tube feeding for
dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet 365:764-772
261. The National Collaborating Centre for Chronic Conditions (2004) Multiple sclerosis - national
guideline for diagnosis and management in primary and secondary care pp.120-123, Royal
College of Physicians of London
262. Todorova A, Vonderheid-Guth B, Dimpfel W (2001) Effects of tolterodine, trospium chloride, and
oxybutynin on the central nervous system. J Clin Pharmacol 41:636-644
263. Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C (2004) Comparison of
the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis:
results of a pilot, randomised, double-blind, crossover trial. J Neurol Sci; 218:103-8
264. Trelles L, Trelles JO, Castro C, Altamirano J, Benzaquen M (1984) Successful treatment of two cases
of intention tremor with clonazepam. Ann Neurol 16:621
265. Trouillas P, Brudon F, Adeleine P (1988) Improvement of cerebellar ataxia with levorotatory form
of 5-hydroxytryptophan. A double-blind study with quantified data processing. Arch Neurol
45:1217-1222
266. Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC,
Massaquoi S, Gomez CM, Coutinho P, Ben Hamida M, Campanella G, Filla A, Schut L, Timann D,
Honnorat J, Nighoghossian N, Manyam B (1997) International Cooperative Ataxia Rating Scale for
pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology
Committee of the World Federation of Neurology. J Neurol Sci 145:205-211
267. Tubridy N, Addison R, Schon F (1999) Long term use of desmopressin for urinary symptoms in
multiple sclerosis. Mult Scler 5:416-417
268. Vahtera T, Haaranen M, Viramo-Koskela AL, Ruutiainen J (1997) Pelvic floor rehabilitation is effective
in patients with multiple sclerosis. Clin Rehabil 11:211-219
269. Valiquette G, Herbert J, Maede-D’Alisera P (1996) Desmopressin in the management of nocturia
in patients with multiple sclerosis. A double-blind, crossover trial. Arch Neurol 53:1270-1275
270. Van Diemen HA, Polman CH, van Dongen TM, van Loenen AC, Nauta JJ, Taphoorn MJ, van
Walbeek HK, Koetsier JC (1992) The effect of 4-aminopyridine on clinical signs in multiple sclerosis:
a randomized, placebo-controlled, double-blind, cross-over study. Ann Neurol 32:123-130
271. Vaney C, Heinzel-Gutenbrunner M, Jobin P, Tschopp F, Gattlen B, Hagen U, Schnelle M, Reif M
(2004) Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment
of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled,
crossover study. Mult Scler 10:417-24
272. Vogel M (1998) Behandlung der Dysarthrie. In: Springer L, Schrey-Dern D (Hrsg.) Dysarthrie.
Grundlagen, Diagnostik, Therapie. Georg Thieme, Stuttgart, New York, 99-130
273. Vogt HJ, Brandl, P, Kockott, G, Schmitz, JR, Wiegand, MH, Schadrack, J, Gierend, M (1997) Double-
59 EMSP, Symptomatic Treatment of Multiple Sclerosis, December 2006 - revised in April 2008